Safety and Tolerability of Stromal Vascular Fraction Combined with β-Tricalcium Phosphate in Posterior Lumbar Interbody Fusion: Phase I Clinical Trial

The rates of pseudarthrosis remain high despite recent advances in bone graft substitutes for spinal fusion surgery. The aim of this single center, non-randomized, open-label clinical trial was to determine the feasibility of combined use of stromal vascular fraction (SVF) and β-tricalcium phosphate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyoung-Tae, Kim, Kwang Gi, Choi, Un Yong, Lim, Sang Heon, Kim, Young Jae, Sohn, Seil, Sheen, Seung Hun, Heo, Chan Yeong, Han, Inbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600447/
https://www.ncbi.nlm.nih.gov/pubmed/33049918
http://dx.doi.org/10.3390/cells9102250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600447/
https://www.ncbi.nlm.nih.gov/pubmed/33049918
http://dx.doi.org/10.3390/cells9102250

Ejemplares similares